JPS433107B1 - - Google Patents
Info
- Publication number
- JPS433107B1 JPS433107B1 JP2710564A JP2710564A JPS433107B1 JP S433107 B1 JPS433107 B1 JP S433107B1 JP 2710564 A JP2710564 A JP 2710564A JP 2710564 A JP2710564 A JP 2710564A JP S433107 B1 JPS433107 B1 JP S433107B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2710564A JPS433107B1 (fr) | 1964-05-14 | 1964-05-14 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2710564A JPS433107B1 (fr) | 1964-05-14 | 1964-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS433107B1 true JPS433107B1 (fr) | 1968-02-05 |
Family
ID=78668842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2710564A Pending JPS433107B1 (fr) | 1964-05-14 | 1964-05-14 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS433107B1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021252761A3 (fr) * | 2020-06-11 | 2022-02-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modes de réalisation de composés monomères et oligomères en tant que contraceptifs et thérapies et procédés de fabrication et d'utilisation associés |
-
1964
- 1964-05-14 JP JP2710564A patent/JPS433107B1/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021252761A3 (fr) * | 2020-06-11 | 2022-02-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modes de réalisation de composés monomères et oligomères en tant que contraceptifs et thérapies et procédés de fabrication et d'utilisation associés |